The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US

American Journal of Medical Genetics, Part A

Volumn 146, Issue 18, 2008, Pages 2385-2389

  Waller, D K ^a,j   Correa, A ^b   Vo, Tuan M ^c   Wang, Y ^d   Hobbs, C ^e   Langlois, P H ^f   Pearson, K ^g   Romitti, P A ^h   Shaw, G M ⁱ   Hecht, J T ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^f TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^g Oklahoma Birth Defects Registry   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ March of Dimes Birth Defects Foundation   (United States)

^j UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Achondroplasia; Birth defects monitoring programs; Paternal age; Population based; Prevalence; Thanatophoric dysplasia

Indexed keywords

ACHONDROPLASIA; ARTICLE; BIRTH DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; FATHER; FEMALE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONITORING; PATERNAL AGE; POPULATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGENY; RISK; THANATOPHORIC DWARFISM; UNITED STATES; ADULT; CONFIDENCE INTERVAL; HEALTH SURVEY; NEWBORN;

ACHONDROPLASIA; ADULT; CONFIDENCE INTERVALS; HUMANS; INFANT, NEWBORN; MALE; ODDS RATIO; PATERNAL AGE; PREVALENCE; SENTINEL SURVEILLANCE; TEXAS; THANATOPHORIC DYSPLASIA; UNITED STATES;

EID: 51449099401     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32485     Document Type: Article

References (21)

1. Andersen PE Jr, Hauge M. 1989. Congenital generalized bone dysplasias: A clinical, radiological, and epidemiological survey. J Med Genet 26:37-44.
2. Camera G, Mastroiacovo P. 1988. Birth prevalence and mutation rate of achondroplasia in the Italian Multicentre Monitoring System for birth defects. Basic Life Sci 48:11.
3. Czeizel A. 1989. Hungarian surveillance of germinal mutations. Lack of detectable increase in indicator conditions caused by germinal mutations following the Chernobyl accident. Hum Genet 82:359-366.
4. Goriely A, McVean GA, van Pelt AM, O'Rourke AW, Wall SA, de Rooij DG, Wilkie AO. 2005. Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci USA 102:6051-6056.
5. Hall JG. 1988. The natural history of achondroplasia. Basic Life Sci 48:3-9.
6. Hecht JT, Francomano CA, Horton WA, Annegers JF. 1987. Mortality in achondroplasia. Am J Hum Genet 41:454-464.
7. Kallen B, Knudsen LB, Mutchinick O, Mastroiacovo P, Lancaster P, Castilla E, Robert E. 1993. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: An international feasibility study. Int J Epidemiol 22:107-115.
8. Karczeski B, Cutting GR. 2004. Thantophoric dysplasia. Available at GeneReviews, www.genetests.org. Initial posting May 21, 2004.
9. Katsumata N, Mikami S, Nagashima-Mikyokawa A, Nimura A, Sato N, Horikawa R, Tanae A, Tanaka T. 2000. Analysis of the FGFR3 Gene in Japanese Patients with Achondroplasia and Hypochrodroplasia. Endocrine J 47:S121-S124.
10. Lian ZH, Zack MM, Erickson DJ. 1986. Paternal age and the occurrence of birth defects. Am J Hum Genet 39:648-660.
11. Mettler G, Fraser FC. 2000. Recurrence risk for sibs of children with sporadic achondroplasia. Am J Med Genet 90:250-251.
12. Ni J, Lu G, Wang W, Chen F, Qin H, Wang D. 2002. Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenital achondroplasia patients (Chinese). Chung-Hua i Hsueh i Chuan Hsueh Tsa Chih 19:205-208.
13. Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S. 1979. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate and radiological features in skull and spine. J Med Genet 16:140-146.
14. Orioli IM, Castilla EE, Barbosa-Neto JG. 1986. The birth prevalence rates for the skeletal dysplasias. J Med Genet 23:238-332.
15. Pehlivan S, Ozkinay F, Okutman O, Coulu O, Ozcan A, Cankaya T, Ulgenalp A. 2003. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene. Turkish J Pediatr 45:99-101.
16. Rasmussen SA, Bieber FR, Benacerraf BR, Lachman RS, Rimoin DL, Holmes LB. 1996. Epidemiology of osteochondrodysplasias: Changing trends due to advances in prenatal diagnosis. Am J Med Genet 61:49-58.
17. Stoll C, Roth MP, Bigel P. 1982. A reexamination on parental age effect on the occurrence of new mutations for achondroplasia. Prog Clin Biol Res 104:419-426.
18. Stoll C, Dott B, Roth MP, Alembik Y. 1989. Birth prevalence rates of skeletal dysplasias. Clin Genet 35:88-92.
19. Vajo Z, Francomano CA, Wilkin DJ. 2000. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis and Crouzon syndrome with acanthosis nigricans. Endocrine Rev 21:23-39.
20. Waller DK, Pujazon MA, Canfield MA, Scheurele AE, Byrne JLB. 2000. Frequency of prenatal diagnosis of birth defects in Houston, Galveston and the Lower Rio Grande Valley of Texas, 1995. Fetal Diagn Therapy 15:348-354.
21. Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Katila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. 1998. Mutations in fibroblast growth-factor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet 63:711-716.